Dynamic Virtual Tumor Cells Powered by Spatial Omics for Translational Oncology

Abstract

Cancer is a serious health problem worldwide. The treatment resistance and variability in clinical outcomes are both challenges for oncology. The tumor microenvironment (TME) plays a significant role in tumor development, treatment response, and spatial heterogeneity. These characteristics vary among different cancer types, patients, and tumor regions. Traditional methods in oncology have not been able to deeply understand the complexity of these interactions without considering spatial factors. In recent years, the development of spatial omics has made significant progress. This technology can analyze gene activity, protein expression, and cell communication within tissues at the same time, providing a deeper understanding of the TME.

This review explores how spatial omics technologies can help connect molecular profiling with clinical applications. We particularly focus on the concept of a "virtual tumor ecosystem." We discuss how spatial omics data can be integrated with computational models to build dynamic, patient-specific digital simulations. These virtual tumor organs can mimic actual tumor behavior and predict treatment responses. The ability to use a patient's own spatial data to simulate therapies and predict drug resistance represents a significant advance in precision cancer medicine. The virtual tumor ecosystem can link spatial omics data with the treatment outcomes of patients, and is expected to enhance the level of personalized cancer treatment. This review summarizes the latest progress in using spatial omics technology to construct cancer models. We also discuss the main challenges faced by this method and its future development prospects. We are aiming to promote the clinical application of related research results and to develop more effective treatment plans for each patient.